Meta-Analysis Open Access
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. May 27, 2024; 16(5): 1407-1419
Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1407
Evaluating effectiveness and safety of combined percutaneous transhepatic gallbladder drainage and laparoscopic cholecystectomy in acute cholecystitis patients: Meta-analysis
Yu Li, Wei-Ke Xiao, Xiao-Jun Li, Hui-Yuan Dong, Department of General Surgery, No. 942 Hospital of PLA, Yinchuan 750004, Ningxia Hui Autonomous Region, China
ORCID number: Yu Li (0009-0004-9658-3817).
Co-first authors: Yu Li and Wei-Ke Xiao.
Author contributions: Li Y and Xiao WK are co-first authors and contributed equally to this work, including design of the study, acquiring and analyzing data from experiments, and writing of the manuscript; Li Y, Xiao WK and Dong HY designed the experiments and conducted clinical data collection; Li Y, Xiao WK and Li XJ performed postoperative follow-up and recorded the data, conducted the collation and statistical analysis, and wrote the original manuscript and revised the paper; all authors read and approved the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yu Li, MD, Doctor, Department of General Surgery, No. 942 Hospital of PLA, No. 898 Shengli South Street, Xingqing District, Yinchuan 750004, Ningxia Hui Autonomous Region, China. leeyutougao@163.com
Received: January 19, 2024
Revised: February 29, 2024
Accepted: April 2, 2024
Published online: May 27, 2024
Processing time: 125 Days and 2.4 Hours

Abstract
BACKGROUND

Acute cholecystitis (AC) is a common disease in general surgery. Laparoscopic cholecystectomy (LC) is widely recognized as the "gold standard" surgical procedure for treating AC. For low-risk patients without complications, LC is the recommended treatment plan, but there is still controversy regarding the treatment strategy for moderate AC patients, which relies more on the surgeon's experience and the medical platform of the visiting unit. Percutaneous transhepatic gallbladder puncture drainage (PTGBD) can effectively alleviate gallbladder inflammation, reduce gallbladder wall edema and adhesion around the gallbladder, and create a "time window" for elective surgery.

AIM

To compare the clinical efficacy and safety of LC or PTGBD combined with LC for treating AC patients, providing a theoretical basis for choosing reasonable surgical methods for AC patients.

METHODS

In this study, we conducted a clinical investigation regarding the combined use of PTGBD tubes for the treatment of gastric cancer patients with AC. We performed searches in the following databases: PubMed, Web of Science, EMBASE, Cochrane Library, China National Knowledge Infrastructure, and Wanfang Database. The search encompassed literature published from the inception of these databases to the present. Subsequently, relevant data were extracted, and a meta-analysis was conducted using RevMan 5.3 software.

RESULTS

A comprehensive analysis was conducted, encompassing 24 studies involving a total of 2564 patients. These patients were categorized into two groups: 1371 in the LC group and 1193 in the PTGBD + LC group. The outcomes of the meta-analysis revealed noteworthy disparities between the PTGBD + LC group and the LC group in multiple dimensions: (1) Operative time: Mean difference (MD) = 17.51, 95%CI: 9.53-25.49, P < 0.01; (2) Conversion to open surgery rate: Odds ratio (OR) = 2.95, 95%CI: 1.90-4.58, P < 0.01; (3) Intraoperative bleeding loss: MD = 32.27, 95%CI: 23.03-41.50, P < 0.01; (4) Postoperative hospital stay: MD = 1.44, 95%CI: 0.14-2.73, P = 0.03; (5) Overall postoperative complication rate: OR = 1.88, 95%CI: 1.45-2.43, P < 0.01; (6) Bile duct injury: OR = 2.17, 95%CI: 1.30-3.64, P = 0.003; (7) Intra-abdominal hemorrhage: OR = 2.45, 95%CI: 1.06-5.64, P = 0.004; and (8) Wound infection: OR = 0. These findings consistently favored the PTGBD + LC group over the LC group. There were no significant differences in the total duration of hospitalization [MD = -1.85, 95%CI: -4.86-1.16, P = 0.23] or bile leakage [OR = 1.33, 95%CI: 0.81-2.18, P = 0.26] between the two groups.

CONCLUSION

The combination of PTGBD tubes with LC for AC treatment demonstrated superior clinical efficacy and enhanced safety, suggesting its broader application value in clinical practice.

Key Words: Acute cholecystitis, Laparoscopic cholecystectomy, Percutaneous transhepatic gallbladder drainage, Meta-analysis, Efficacy

Core Tip: Laparoscopic cholecystectomy (LC) is the standard surgical procedure for treating acute cholecystitis (AC), but postoperative complications and patient mortality are relatively high. Percutaneous transhepatic gallbladder drainage (PTGBD) can quickly drain infected bile, reduce gallbladder tension, and is often used in combination with delayed LC in clinical practice, but PTGBD is associated with more adverse long-term outcomes. The meta-analysis results of this study showed that the combination of PTGBD and LC for the treatment of AC has short surgical time, low conversion rate to open surgery, less intraoperative bleeding, and low overall incidence of complications, which is worthy of promotion.



INTRODUCTION

Acute cholecystitis (AC) is a prevalent acute abdominal pathology in general surgery and is predominantly attributed to etiologies such as gallstones, bile stasis, and bacterial infections. With the rapid advancements in laparoscopic technologies, laparoscopic cholecystectomy (LC) has emerged as the standard surgical approach, superseding open cholecystectomy for gallbladder pathologies. Despite this progress, mortality rates in high-risk cohorts remain substantial, ranging between 3.7% and 41.0%[1]. Percutaneous transhepatic gallbladder drainage (PTGBD) is an expedited method for draining infected bile, thereby alleviating gallbladder tension and reducing the risk of rupture due to bile-induced chemical irritation. This approach effectively diminishes toxin absorption, mitigates gallbladder obstruction, and stabilizes the disease trajectory, with some patients attaining complete resolution[2]. LC is the preferred modality for uncomplicated, low-risk patients[3]. However, in moderate AC scenarios, characterized by potential organ failure and significant local inflammatory adhesions, the combination of PTGBD with delayed LC appears more judicious[4]. Despite its utility, PTGBD is not an unequivocal therapeutic modality and is linked to less favorable long-term results, including prolonged hospitalization periods and heightened rates of readmission[5,6]. International guidelines exhibit variability in recommending LC over PTGBD for AC management[3,7,8]. Additionally, most of the current domestic and international research on the combination of PTGBD and LC for treating AC has involved single-center studies with small sample sizes. In this study, we sought to perform a comparative evaluation of the clinical effectiveness and safety of LC and the combination of PTGBD and LC in the management of AC by employing an evidence-based medicine framework. This comparison was intended to provide a theoretical basis for appropriately selecting surgical methods for patients with AC.

MATERIALS AND METHODS
Inclusion and exclusion criteria

The inclusion criteria were as follows: (1) Study type: Clinical randomized controlled trials (RCTs); (2) Subjects: Patients diagnosed with AC; (3) Intervention: Control group receiving LC; Experimental group receiving PTGBD combined with LC; and (4) Outcome measures: Clinical efficacy indicators, including operative time, intraoperative blood loss, conversion to open surgery rate, postoperative and total hospital stay; safety indicators, including overall postoperative complication rate, and incidence of bile leakage, bile duct injury, intra-abdominal hemorrhage, and wound infection. The exclusion criteria were as follows: (1) Basic research, abstracts, conference papers, reviews, meta-analyses, systematic reviews, or case reports; (2) Literature not in Chinese or English; (3) Duplicate publications, including studies that were republished or similar in research direction by the same author; (4) Studies with a sample size of fewer than 20 subjects; and (5) Literature where the full text was unavailable, inappropriate statistical methods were used, data could not be extracted, or data were incomplete.

Literature search strategy

Through computerized searches, we conducted an extensive exploration across a multitude of databases, including PubMed, Web of Science, EMBASE, Cochrane Library, China National Knowledge Infrastructure, and Wanfang, with the aim of identifying RCTs pertaining to the combined management of AC using PTGBD and LC. Our search strategy included specific English terms, including "acute cholecystitis" or "AC", "laparoscopic cholecystectomy" or "LC" and "percutaneous transhepatic gallbladder" or "PTGBD". The corresponding Chinese search terms included: Acute cholecystitis, laparoscopic cholecystectomy, percutaneous transhepatic gallbladder puncture and drainage, alongside others. Our search efforts spanned from the inception of these databases to the present day. This manuscript was meticulously crafted in accordance with the directives set forth in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Furthermore, our systematic review has been officially registered with PROSPERO under Registration No. 2023110106.

Data extraction

Two researchers carried out a thorough and independent literature screening process following preestablished inclusion and exclusion criteria. Initially, they meticulously scrutinized the titles and abstracts to exclude studies that were evidently unrelated to the research focus. Following this initial screening, the full texts of potentially relevant studies underwent a comprehensive review to validate their eligibility. Any discrepancies that emerged during this process were resolved through consultation with a third researcher. The data extraction procedure encompassed critical details, including the titles of the included literature, authors, publication journals, publication year, study sample size, inclusion periods for samples, treatment modalities, outcome measures, and other pertinent information.

Quality assessment of the included studies

We utilized the Newcastle-Ottawa scale (NOS) to evaluate the methodological quality of the included studies. The NOS assessment criteria encompass the following dimensions: The selection of study groups (comprising 4 items with a maximum score of 4 points), comparability of the groups (1 item with a potential score of up to 2 points), and assessment of outcomes (comprising 3 items with a potential score of up to 3 points). The highest achievable score was 9 points, with a score of ≥ 6 points indicating high-quality literature.

Statistical analysis

The data were analyzed utilizing RevMan 5.3 software for meta-analysis. For dichotomous variables, odds ratios (ORs) in combination with 95%CI were utilized as the primary outcome measures. For continuous variables, the mean difference (MD) and 95%CI were used. The assessment of study heterogeneity was performed using the statistic. A fixed-effects model was adopted when P was ≥ 0.1 and I² was < 50%, while a random-effects model was utilized when P was < 0.1 and I² was ≥ 50%. The sources of heterogeneity were meticulously investigated, and publication bias was evaluated through funnel plot analysis. A P value < 0.05 was considered to indicate statistical significance.

RESULTS
Literature search results

According to the literature search strategy, a comprehensive search across various databases was conducted. Initially, 672 articles were identified. After removal of duplicates, 235 articles were excluded. After scrutinizing the titles and abstracts, 369 articles were subsequently excluded. After thorough examination of the full texts and additional assessment, 43 articles were eliminated due to inappropriate intervention measures or data that could not be extracted. Overall, a total of 24 articles were included in this study. The details of the literature selection process and its outcomes are depicted in Figure 1.

Figure 1
Figure 1 Flow diagram depicting the screening and inclusion process of the studies. CNKI: China National Knowledge Infrastructure.
Basic characteristics of the included studies

In the course of this investigation, of the 24 articles that were included, 7 were published in Chinese, while the remaining 17 were published in English. These articles collectively encompassed a cohort of 2564 patients, with 1371 allocated to the control group and 1193 to the experimental group. Table 1 provides a comprehensive overview of the fundamental characteristics of the studies included in this analysis.

Table 1 Overview of the included study characteristics.
Ref.
Country
LC
Timing of LC after admission
PTGBD + LC
Time of LC after PTGBD
NOS
Duan and Li[9], 2021China44Immediately48Within 1-3 months8
Hao and Fan[10], 2022China82Within 24 h118Within 1-3 months8
Liu[11], 2018China40Not specified40Simultaneous8
Ma et al[12], 2020China57Not specified57After 1 month7
Wu and Kuang[13], 2017China20Within 3 months14Within 3 months8
Zhan et al[14], 2023China38Not specified384-6 wk8
Zhou et al[15], 2019China47Within 3 h473-9 wk8
El-Gendi et al[16], 2017Egypt75After 72 h756 wk8
Chikamori et al[17], 2002Japan9Not specified31Not specified7
Choi et al[18], 2012Korea63Within 72 h40Average 7.9 d8
Hu et al[19], 2015China35Not specified356-10 wk8
Jung and Park[20], 2017Korea166Not specified1282-238
Karakayali et al[21], 2014Turkey48Within 72 h434-8 wk8
Ke and Wu et al[22], 2018China47After 72 h491-1096 d8
Kim et al[23], 2009Korea60Not specified35Within 7 d8
Kim et al[24], 2011Korea147Mean time interval 42.2 h97Mean time interval 188.4 h8
Lee et al[25], 2017Korea4136 had LC within 24 h, 3 had LC 1-3 d, 2 had LC > 7 d44Mean 30 d8
Liu et al[26], 2020China4557.6 ± 12.2 h5862.4 ± 11.5 h8
Na et al[27], 2015Korea77Not specified39Not specified7
Ni et al[28], 2015China33Not specified26Within 1 year8
Pan et al[29], 2023Taiwan67Immediately23Not specified8
Tsumura et al[30], 2004Japan73Within 24 h60Not specified8
Yamazaki et al[31], 2023Japan22Immediately13After 2 months8
Yang and Tian[32], 2022China35After 7 d35After 40 d8
Clinical efficacy meta-analysis results

Operative time: In this comprehensive analysis, all 24 studies[9-32] included a comparative assessment of operative times across the two groups. The heterogeneity test indicated a highly significant variance (P < 0.00001, = 94%), thus indicating the application of a random-effects model for the analysis. The meta-analysis demonstrated a significantly shorter operative duration in the PTGBD + LC group than in the LC group, with an average decrease of 17.51 min (95%CI: 9.53-25.49, P < 0.0001). For a visual depiction of these results, please refer to Figure 2A.

Figure 2
Figure 2 Forest plot depicting comparison between the percutaneous transhepatic gallbladder puncture drainage + laparoscopic cholecystectomy group and the laparoscopic cholecystectomy group. A: Forest plot depicting the operation time comparison between the percutaneous transhepatic gallbladder puncture drainage (PTGBD) + laparoscopic cholecystectomy (LC) group and the LC group; B: Forest plot illustrating the comparison of the conversion rate to open surgery between the PTGBD + LC group and the LC group; C: Forest plot illustrating the comparison of intraoperative bleeding between the PTGBD + LC group and the LC group; D: Forest plot depicting the comparison of overall hospital stay between the PTGBD + LC group and the LC group; E: Forest plot depicting the comparison of postoperative hospital stay between the PTGBD + LC group and the LC group; F: Forest plot illustrating the comparison of postoperative complications between the PTGBD + LC group and the LC group; G: Forest plot illustrating the comparison of bile leakage rates between the PTGBD + LC group and the LC group; H: Forest plot depicting the comparison of wound infection rates between the PTGBD + LC group and the LC group; I: Forest plot depicting intraperitoneal hemorrhage in the PTGBD + LC group compared to the LC group; J: Forest plot comparing bile duct injury incidence between the PTGBD + LC group and the LC group. PTGBD: Percutaneous transhepatic gallbladder puncture drainage; LC: Laparoscopic cholecystectomy.

Conversion to open surgery rate: Twenty-two studies[9,10,12-28,30-32] compared the rate of conversion to open surgery between the two groups. The heterogeneity test results showed P = 0.005 and = 50%, indicating significant heterogeneity. Consequently, a random effects model was employed for the analysis. The outcomes of the meta-analysis revealed a statistically notable difference: In comparison to the LC group, the PTGBD + LC group displayed a decreased conversion rate to open surgery, with an average reduction of 2.95%. This reduction was statistically significant, with a 95%CI of 1.90 to 4.58, and the P value was less than 0.00001 (Figure 2B).

Intraoperative blood loss: Seventeen studies[9-16,18,19,22,26-28,30-32] compared intraoperative blood loss between the two groups. The heterogeneity test results showed P < 0.00001 and = 97%, necessitating the use of a random-effects model for the analysis. The meta-analysis revealed that the PTGBD + LC group exhibited a significant reduction in intraoperative blood loss compared to the LC group, with an average decrease of 32.27 mL, which was statistically significant (95%CI: 23.03-41.50, P < 0.00001; Figure 2C).

Total hospital stay: Fifteen studies[10,11,15,17-20,23-28,31,32] conducted a comparative assessment of the total hospital stay between the two groups. Heterogeneity testing produced significant results (P < 0.00001, = 98%), which necessitated the adoption of a random-effects model for the analysis. The meta-analysis revealed that the PTGBD + LC group had a marginally longer total hospital stay than did the LC group, with an average increase of 1.85 d; however, it is important to note that this difference did not achieve statistical significance (95%CI: -4.86-1.16, P = 0.23; Figure 2D).

Postoperative hospital stay: Thirteen studies[9,12-14,17,20-22,24,25,27,30,31] conducted a comparative analysis of postoperative hospital stays between the two groups. The heterogeneity test results showed P < 0.00001 and = 94%, necessitating the application of a random-effects model for the analysis. The meta-analysis revealed a statistically significant difference: The PTGBD + LC group demonstrated a noteworthy reduction in postoperative hospital stay compared to the LC group, with an average decrease of 1.44 d (95%CI: 0.14-2.73, P = 0.03; Figure 2E).

Safety meta-analysis results

Postoperative complication rate: Twenty-two studies[9-24,26-29,31,32] compared the overall postoperative complication rates between the groups. The heterogeneity test showed P = 0.0001 and = 61%, which necessitated the adoption of a random-effects model for the analysis. A significant reduction in the overall incidence of complications was observed in the PTGBD + LC group compared to the LC group. This reduction amounted to an average of 1.88 patients (95%CI: 1.45-2.43, P < 0.00001; Figure 2F).

Bile leakage: Seventeen studies[9,13-16,18-23,26,27,29-32] compared the incidence of postoperative bile leakage between the two groups. The heterogeneity test showed P = 0.40 and = 5%, confirming the use of a fixed-effects model for the analysis. After conducting the meta-analysis, it was evident that the PTGBD + LC group exhibited a lower incidence of postoperative bile leakage than did the LC group, with an average reduction of 1.33 patients. Nevertheless, it is noteworthy that this disparity did not reach statistical significance, as indicated by the 95%CI: 0.81-2.18, P = 0.26 (Figure 2G).

Wound infection: Sixteen studies[9,10,12,14-16,19-21,23,25,26,28-31] compared the incidence of postoperative wound infection between the two groups. The results of the heterogeneity test demonstrated P = 0.67 and = 0%, indicating minimal heterogeneity. Consequently, a fixed-effects model was employed for the analysis. The meta-analysis findings demonstrated a statistically significant reduction in postoperative wound infections in the PTGBD + LC group compared with the LC group, with an average decrease of 2.17 patients (95%CI: 1.30-3.64, P = 0.003; Figure 2H).

Intra-abdominal hemorrhage: Ten studies[9,10,13,15-17,20,26,27,32] compared the incidence of postoperative intra-abdominal hemorrhage between the groups. The heterogeneity test results, with P = 0.67 and = 0%, supported the application of a fixed-effects model for the analysis. The meta-analysis revealed a notable difference: The PTGBD + LC group exhibited a significantly lower incidence of postoperative intra-abdominal hemorrhage than did the LC group, with an average reduction of 2.45 patients (95%CI: 1.06-5.64, P = 0.004; Figure 2I).

Bile duct injury: Six studies[12,14,16,17,29,30] compared the incidence of postoperative bile duct injury between the two groups. The heterogeneity test results showed P = 0.67 and = 0%, thus confirming the use of a fixed-effects model for the analysis. The meta-analysis demonstrated that the PTGBD + LC group exhibited a significantly lower incidence of postoperative bile duct injuries than did the LC group, with an average reduction of 4.46 patients (95%CI: 1.42-14.02, P = 0.01; Figure 2J).

Publication bias: Publication bias analysis was conducted using funnel plots for various outcomes, which included operative time, conversion to open surgery rate, intraoperative blood loss, total hospital stay, postoperative hospital stay, overall postoperative complication rate, postoperative bile leakage, bile duct injury, intra-abdominal hemorrhage, and incidence of wound infection. The results indicated good symmetry in the funnel plots, suggesting that the study results are minimally influenced by publication bias (Figure 3).

Figure 3
Figure 3 Funnel plots of each outcome. A: Operative time; B: Conversion rate to open surgery; C: Intraoperative bleeding; D: Overall hospital stay; E: Postoperative hospital stay; F: Postoperative complications; G: Bile leakage; H: Wound infection; I: Intraperitoneal hemorrhage; J: Bile duct injury. MD: Mean difference; OR: Odds ratio.
DISCUSSION

A meta-analysis refers to the use of statistical methods to analyze and summarize multiple collected research studies, providing a quantified average effect to answer research questions. Its advantage lies in increasing the credibility of the conclusions by enlarging the sample size. This study included 24 articles and included a meta-analysis aimed at comparing the clinical effectiveness and safety of LC combined with PTGBD and LC for the treatment of AC, providing valuable clinical insights. The meta-analysis revealed that compared with the LC group, the PTGBD + LC group had a shorter surgery time (MD = 17.51, 95%CI: 9.53-25.49, P < 0.01), a lower rate of conversion to open surgery (OR = 2.95, 95%CI: 1.90-4.58, P < 0.01), less intraoperative bleeding (MD = 32.27, 95%CI: 23.03-41.50, P < 0.01), a shorter postoperative hospital stay (MD = 1.44, 95%CI: 0.14-2.73, P = 0.03), and a lower overall postoperative complication rate (OR = 1.88, 95%CI: 1.45-2.43, P < 0.01). There were also lower incidences of postoperative bile duct injury (OR = 14.46, 95%CI: 1.42-14.02, P = 0.01), intra-abdominal bleeding (OR = 2.45, 95%CI: 1.06-5.64, P = 0.004), and wound infection (OR = 2.17, 95%CI: 1.30-3.64, P = 0.003), indicating that PTGBD combined with LC is more effective and safer for treating AC than LC alone.

The short surgical time in the PTGBD + LC group may be related to the relief of local inflammation after PTGBD. As a minimally invasive surgery, PTGBD reduces gallbladder swelling, gallbladder wall edema, and inflammation around the gallbladder[33]. PTGBD can immediately alleviate the clinical symptoms of AC in patients in good preoperative condition[34]. In addition, PTGBD can be used for cholangiography to display the anatomical structure of the biliary tract and provide clear information on the surgical site[35].

Previous studies have concluded that the fundamental reason for transitioning to open surgery is recurrent and progressive inflammation accompanied by gallbladder wall swelling and edema[36,37]. The low rate of conversion to open surgery in the PTGBD + LC group may be attributed to PTGBD, as PTGBD has the ability to alleviate inflammatory gallbladder adhesion. After PTGBD, patients have a reduced gallbladder wall thickness, clearer anatomical structure of the gallbladder triangle, reduced intraoperative bleeding, and a reduced risk of biliary tract injury.

Our analysis of intraoperative bleeding revealed less bleeding in the PTGBD + LC group than in the LC group. PTGBD can immediately alleviate the decompression of swollen gallbladders and inflammation around the gallbladder, preventing the development of fibrosis in the Calot triangle[34]. With the help of PTGBD, the surgical field of view of the Calot triangle is clearer, which facilitates LC and reduces intraoperative bleeding.

Our analysis of hospitalization time revealed that the postoperative hospitalization time of the PTGBD + LC group was significantly shorter than that of the LC group. It is possible that the patient's gallbladder wall congestion, edema, and inflammation caused by gallbladder inflammation gradually subside in the short term after PTGBD, making it easier to distinguish anatomy and thereby reducing surgical difficulty and shortening surgical time[25,33]. Our analysis revealed that the total incidence of postoperative complications in the PTGBD + LC group was low, possibly because PTGBDD was associated with minimal trauma. At the same time, supportive treatment, such as systemic anti-infection therapy, can quickly alleviate clinical symptoms, prevent further deterioration of the condition, and provide sufficient time for the treatment of complications[38].

The results of the meta-analysis indicated that the combined hospital stay in the PTGBD + LC group was slightly longer than that in the PTGBD + LC group, but the difference did not reach statistical significance (MD = -1.85, 95%CI: -4.86-1.16, P = 0.23). The extended total hospital stay in the PTGBD + LC group can be attributed to the requirement for a longer duration or even two hospital admissions to complete the treatment, which may be considered the sole drawback of PTGBD.

The presence of publication bias is indicated by the observed asymmetry in the funnel plot. Significant heterogeneity was also observed in some studies, possibly related to variations in surgical experience, surgical instruments, severity grading of AC, and discharge criteria. The interval between PTGBD tube placement and LC was another important factor contributing to heterogeneity. The optimal timing for delayed LC after PTGBD remains controversial, with different experiences and policies at various centers leading to varied optimal timing. Jia et al[39] noted that patients who underwent LC within 5 d after PTGBD had significantly less surgical time, bleeding, postoperative peritoneal drainage duration, postoperative oral intake time, and postoperative complications than those who exceeded 5 d. Finally, most of the included studies were performed in Asia, and the data regarding LC and PTGBD in Europe and America were unclear. RCTs and multicenter studies with large sample sizes are needed to verify the outcomes of this meta-analysis.

Meta-analysis is an observational study type and inevitably possesses biases in its design. The limitations of this study include the following: (1) The inclusion of a restricted number of research articles with small sample sizes has implications for the generalizability of conclusions and increases the vulnerability to publication bias; (2) Variability in the interval from PTGBD to LC in the included studies; and (3) The focus on only English and Chinese literature, neglecting gray literature and other languages, which might introduce certain biases in the results.

CONCLUSION

In summary, this meta-analysis revealed that the amalgamation of PTGBD combined with LC conspicuously enhances clinical efficacy while concurrently mitigating the frequency of postoperative complications in individuals afflicted with AC.

Footnotes

Provenance and peer review: Unsolicited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Gastroenterology and hepatology

Country/Territory of origin: China

Peer-review report’s scientific quality classification

Grade A (Excellent): 0

Grade B (Very good): 0

Grade C (Good): C, C

Grade D (Fair): 0

Grade E (Poor): 0

P-Reviewer: Cekici Y, Turkey; Hung YP, Taiwan S-Editor: Li L L-Editor: A P-Editor: Xu ZH

References
1.  Lisotti A, Linguerri R, Bacchilega I, Cominardi A, Marocchi G, Fusaroli P. EUS-guided gallbladder drainage in high-risk surgical patients with acute cholecystitis-procedure outcomes and evaluation of mortality predictors. Surg Endosc. 2022;36:569-578.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 7]  [Article Influence: 2.3]  [Reference Citation Analysis (1)]
2.  Choi JH, Kim HW, Lee JC, Paik KH, Seong NJ, Yoon CJ, Hwang JH, Kim J. Percutaneous transhepatic versus EUS-guided gallbladder drainage for malignant cystic duct obstruction. Gastrointest Endosc. 2017;85:357-364.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 38]  [Article Influence: 5.4]  [Reference Citation Analysis (0)]
3.  Pisano M, Allievi N, Gurusamy K, Borzellino G, Cimbanassi S, Boerna D, Coccolini F, Tufo A, Di Martino M, Leung J, Sartelli M, Ceresoli M, Maier RV, Poiasina E, De Angelis N, Magnone S, Fugazzola P, Paolillo C, Coimbra R, Di Saverio S, De Simone B, Weber DG, Sakakushev BE, Lucianetti A, Kirkpatrick AW, Fraga GP, Wani I, Biffl WL, Chiara O, Abu-Zidan F, Moore EE, Leppäniemi A, Kluger Y, Catena F, Ansaloni L. 2020 World Society of Emergency Surgery updated guidelines for the diagnosis and treatment of acute calculus cholecystitis. World J Emerg Surg. 2020;15:61.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 146]  [Cited by in F6Publishing: 153]  [Article Influence: 38.3]  [Reference Citation Analysis (1)]
4.  Yamada K, Yamashita Y, Yamada T, Takeno S, Noritomi T. Optimal timing for performing percutaneous transhepatic gallbladder drainage and subsequent cholecystectomy for better management of acute cholecystitis. J Hepatobiliary Pancreat Sci. 2015;22:855-861.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 21]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
5.  Sanaiha Y, Juo YY, Rudasill SE, Jaman R, Sareh S, de Virgilio C, Benharash P. Percutaneous cholecystostomy for grade III acute cholecystitis is associated with worse outcomes. Am J Surg. 2020;220:197-202.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 8]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
6.  Loozen CS, van Santvoort HC, van Duijvendijk P, Besselink MG, Gouma DJ, Nieuwenhuijzen GA, Kelder JC, Donkervoort SC, van Geloven AA, Kruyt PM, Roos D, Kortram K, Kornmann VN, Pronk A, van der Peet DL, Crolla RM, van Ramshorst B, Bollen TL, Boerma D. Laparoscopic cholecystectomy versus percutaneous catheter drainage for acute cholecystitis in high risk patients (CHOCOLATE): multicentre randomised clinical trial. BMJ. 2018;363:k3965.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 128]  [Cited by in F6Publishing: 137]  [Article Influence: 22.8]  [Reference Citation Analysis (0)]
7.  Hall BR, Armijo PR, Krause C, Burnett T, Oleynikov D. Emergent cholecystectomy is superior to percutaneous cholecystostomy tube placement in critically ill patients with emergent calculous cholecystitis. Am J Surg. 2018;216:116-119.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 25]  [Cited by in F6Publishing: 27]  [Article Influence: 3.9]  [Reference Citation Analysis (0)]
8.  Okamoto K, Suzuki K, Takada T, Strasberg SM, Asbun HJ, Endo I, Iwashita Y, Hibi T, Pitt HA, Umezawa A, Asai K, Han HS, Hwang TL, Mori Y, Yoon YS, Huang WS, Belli G, Dervenis C, Yokoe M, Kiriyama S, Itoi T, Jagannath P, Garden OJ, Miura F, Nakamura M, Horiguchi A, Wakabayashi G, Cherqui D, de Santibañes E, Shikata S, Noguchi Y, Ukai T, Higuchi R, Wada K, Honda G, Supe AN, Yoshida M, Mayumi T, Gouma DJ, Deziel DJ, Liau KH, Chen MF, Shibao K, Liu KH, Su CH, Chan ACW, Yoon DS, Choi IS, Jonas E, Chen XP, Fan ST, Ker CG, Giménez ME, Kitano S, Inomata M, Hirata K, Inui K, Sumiyama Y, Yamamoto M. Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25:55-72.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 293]  [Cited by in F6Publishing: 397]  [Article Influence: 56.7]  [Reference Citation Analysis (0)]
9.  Duan RH, Li S. The effect of percutaneous transhepatic gallbladder puncture drainage and sequential laparoscopic cholecystectomy on traumatic stress and energy metabolism in elderly patients with acute cholecystitis. Zhongguo Laonianxue Zazhi. 2021;41:5210-5213.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Hao XQ, Fan W. Comparison of clinical efficacy between laparoscopic cholecystectomy and percutaneous liver gallbladder puncture drainage sequential treatment for patients with acute cholecystitis. Zhongguo Linchuang Yisheng Zazhi. 2022;50:694-696.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Liu HL. The application value of percutaneous liver gallbladder puncture drainage combined with laparoscopic cholecystectomy in acute cholecystitis. Linchuang Junyi Zazhi. 2018;46:1482-1483.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Ma HZ, Yao X, Zhang XB, Shi G. A comparative study between two-stage laparoscopic cholecystectomy and emergency laparoscopic cholecystectomy after PTGD surgery. Linchuang Jizhen Zazhi. 2020;21:34-37.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Wu JH, Ruan JQ Kuang NL. Percutaneous transhepatic gallbladder drainage combined with laparoscopic cholecystectomy in the treatment of acute cholecystitis with diabetes. Gandanyi Waike Zazhi. 2017;6:100-103.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Zhan F, Zhang K, Cheng BL, Zhang Y, Jiang C. Comparison of propensity score matching between sequential laparoscopic cholecystectomy (LC) and primary LC in the treatment of grade II acute cholecystitis after percutaneous transhepatic gallbladder puncture and drainage. Zhongguo Putong Waike Zazhi. 2023;32:171-180.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Zhou ZL, Mei Y, Yang XH, Dai J. Percutaneous transhepatic gallbladder drainage and delayed laparoscopic cholecystectomy combination in the treatment of patients with acute cholecystitis. Shiyong Ganzangbing Zazhi. 2019;22:597-600.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  El-Gendi A, El-Shafei M, Emara D. Emergency Versus Delayed Cholecystectomy After Percutaneous Transhepatic Gallbladder Drainage in Grade II Acute Cholecystitis Patients. J Gastrointest Surg. 2017;21:284-293.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 32]  [Article Influence: 4.6]  [Reference Citation Analysis (0)]
17.  Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Early scheduled laparoscopic cholecystectomy following percutaneous transhepatic gallbladder drainage for patients with acute cholecystitis. Surg Endosc. 2002;16:1704-1707.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 56]  [Cited by in F6Publishing: 56]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
18.  Choi JW, Park SH, Choi SY, Kim HS, Kim TH. Comparison of clinical result between early laparoscopic cholecystectomy and delayed laparoscopic cholecystectomy after percutaneous transhepatic gallbladder drainage for patients with complicated acute cholecystitis. Korean J Hepatobiliary Pancreat Surg. 2012;16:147-153.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 19]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
19.  Hu YR, Pan JH, Tong XC, Li KQ, Chen SR, Huang Y. Efficacy and safety of B-mode ultrasound-guided percutaneous transhepatic gallbladder drainage combined with laparoscopic cholecystectomy for acute cholecystitis in elderly and high-risk patients. BMC Gastroenterol. 2015;15:81.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 15]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
20.  Jung BH, Park JI. Impact of scheduled laparoscopic cholecystectomy in patients with acute cholecystitis, following percutaneous transhepatic gallbladder drainage. Ann Hepatobiliary Pancreat Surg. 2017;21:21-29.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 7]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
21.  Karakayali FY, Akdur A, Kirnap M, Harman A, Ekici Y, Moray G. Emergency cholecystectomy vs percutaneous cholecystostomy plus delayed cholecystectomy for patients with acute cholecystitis. Hepatobiliary Pancreat Dis Int. 2014;13:316-322.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 38]  [Cited by in F6Publishing: 39]  [Article Influence: 3.9]  [Reference Citation Analysis (0)]
22.  Ke CW, Wu SD. Comparison of Emergency Cholecystectomy with Delayed Cholecystectomy After Percutaneous Transhepatic Gallbladder Drainage in Patients with Moderate Acute Cholecystitis. J Laparoendosc Adv Surg Tech A. 2018;28:705-712.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 12]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
23.  Kim HO, Ho Son B, Yoo CH, Ho Shin J. Impact of delayed laparoscopic cholecystectomy after percutaneous transhepatic gallbladder drainage for patients with complicated acute cholecystitis. Surg Laparosc Endosc Percutan Tech. 2009;19:20-24.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 42]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
24.  Kim IG, Kim JS, Jeon JY, Jung JP, Chon SE, Kim HJ, Kim DJ. Percutaneous transhepatic gallbladder drainage changes emergency laparoscopic cholecystectomy to an elective operation in patients with acute cholecystitis. J Laparoendosc Adv Surg Tech A. 2011;21:941-946.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 20]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
25.  Lee R, Ha H, Han YS, Kwon HJ, Ryeom H, Chun JM. Percutaneous transhepatic gallbladder drainage followed by elective laparoscopic cholecystectomy for patients with moderate to severe acute cholecystitis. Medicine (Baltimore). 2017;96:e8533.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 15]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
26.  Liu P, Liu C, Wu YT, Zhu JY, Zhao WC, Li JB, Zhang H, Yang YX. Impact of B-mode-ultrasound-guided transhepatic and transperitoneal cholecystostomy tube placement on laparoscopic cholecystectomy. World J Gastroenterol. 2020;26:5498-5507.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 3]  [Cited by in F6Publishing: 2]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
27.  Na BG, Yoo YS, Mun SP, Kim SH, Lee HY, Choi NK. The safety and efficacy of percutaneous transhepatic gallbladder drainage in elderly patients with acute cholecystitis before laparoscopic cholecystectomy. Ann Surg Treat Res. 2015;89:68-73.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 20]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
28.  Ni Q, Chen D, Xu R, Shang D. The Efficacy of Percutaneous Transhepatic Gallbladder Drainage on Acute Cholecystitis in High-Risk Elderly Patients Based on the Tokyo Guidelines: A Retrospective Case-Control Study. Medicine (Baltimore). 2015;94:e1442.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 17]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
29.  Pan YL, Wu PS, Chen JH, Chen LY, Fang WL, Chau GY, Lee KC, Hou MC. Early cholecystectomy following percutaneous transhepatic gallbladder drainage is effective for moderate to severe acute cholecystitis in the octogenarians. Arch Gerontol Geriatr. 2023;106:104881.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
30.  Tsumura H, Ichikawa T, Hiyama E, Kagawa T, Nishihara M, Murakami Y, Sueda T. An evaluation of laparoscopic cholecystectomy after selective percutaneous transhepatic gallbladder drainage for acute cholecystitis. Gastrointest Endosc. 2004;59:839-844.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 30]  [Cited by in F6Publishing: 25]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
31.  Yamazaki S, Shimizu A, Kubota K, Notake T, Yoshizawa T, Masuo H, Sakai H, Hosoda K, Hayashi H, Yasukawa K, Umemura K, Kamachi A, Goto T, Tomida H, Seki H, Shimura M, Soejima Y. Urgent versus elective laparoscopic cholecystectomy following percutaneous transhepatic gallbladder drainage for high-risk grade II acute cholecystitis. Asian J Surg. 2023;46:431-437.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 1]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
32.  Yang JP, Tian Z. Analysis of the Effect of Laparoscopic Cholecystectomy for Acute Cholecystitis after Percutaneous Transhepatic Gallbladder Puncture and Drainage. Evid Based Complement Alternat Med. 2022;2022:2071326.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
33.  Kamezaki H, Tsuyuguchi T, Shimura K, Sakamoto D, Senoo J, Mizumoto H, Kubota M, Yoshida Y, Azemoto R, Sugiyama H, Kato N. Safety and Efficacy of Early Tube Removal Following Percutaneous Transhepatic Gallbladder Drainage: an Observational Study. Surg Laparosc Endosc Percutan Tech. 2020;30:164-168.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 1]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
34.  Ihama Y, Fukazawa M, Ninomiya K, Nagai T, Fuke C, Miyazaki T. Peritoneal bleeding due to percutaneous transhepatic gallbladder drainage: An autopsy report. World J Hepatol. 2012;4:288-290.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in F6Publishing: 3]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
35.  Fidelman N, Kerlan RK Jr, Laberge JM, Gordon RL. Accuracy of percutaneous transhepatic cholangiography in predicting the location and nature of major bile duct injuries. J Vasc Interv Radiol. 2011;22:884-892.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 14]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
36.  Lo CM, Liu CL, Fan ST, Lai EC, Wong J. Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg. 1998;227:461-467.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 359]  [Cited by in F6Publishing: 326]  [Article Influence: 12.5]  [Reference Citation Analysis (0)]
37.  Kolla SB, Aggarwal S, Kumar A, Kumar R, Chumber S, Parshad R, Seenu V. Early versus delayed laparoscopic cholecystectomy for acute cholecystitis: a prospective randomized trial. Surg Endosc. 2004;18:1323-1327.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 181]  [Cited by in F6Publishing: 174]  [Article Influence: 8.7]  [Reference Citation Analysis (0)]
38.  Tao P, Wu XY, Zhang L. Clinical effect of ultrasound guided percutaneous transhepatic gallbladder drainage in treatment of acute cholecystitis in elderly patients. Linchuang Gandanbing Zazhi. 2016;32:1929-1931.  [PubMed]  [DOI]  [Cited in This Article: ]
39.  Jia B, Liu K, Tan L, Jin Z, Fu Y, Liu Y. Evaluation of the Safety and Efficacy of Percutaneous Transhepatic Gallbladder Drainage Combined with Laparoscopic Cholecystectomy for Treating Acute Complicated Cholecystitis. Am Surg. 2018;84:133-136.  [PubMed]  [DOI]  [Cited in This Article: ]